Novel hybrid lipid nanocapsules loaded with a therapeutic monoclonal antibody – Bevacizumab – and Triamcinolone acetonide for combined therapy in neovascular ocular pathologies-Reference-Cited by-同舟云学术

Novel hybrid lipid nanocapsules loaded with a therapeutic monoclonal antibody – Bevacizumab – and Triamcinolone acetonide for combined therapy in neovascular ocular pathologies

Published:2021-02 Issue: Volume:119 Page:111398
ISSN:0928-4931
Container-title:Materials Science and Engineering: C
language:en
Short-container-title:Materials Science and Engineering: C

Author:

Formica María Lina,Legeay Samuel,Bejaud Jérôme,Montich Guillermo Gabriel,Ullio Gamboa Gabriela Verónica,Benoit Jean-Pierre,Palma Santiago Daniel

Funder

Fondo para la Investigación Científica y Tecnológica de la República Argentina

Secretaría de Ciencia y Tecnología de la Universidad Nacional de Córdoba

Publisher

Elsevier BV

Subject

Biomaterials,Bioengineering,Mechanics of Materials

Reference43 articles.

1. A novel phase inversion-based process for the preparation of lipid nanocarriers;Heurtault;Pharm. Res.,2002

2. Mediators of ocular angiogenesis;Qazi;J. Genet.,2009

3. Cabral T, Mello LGM, Lima LH, Polido J, Regatieri C V., Belfort R, et al. Retinal and choroidal angiogenesis: a review of new targets. Int J Retin Vitr [Internet]. 2017; 3(1):31. Available from: http://journalretinavitreous.biomedcentral.com/articles/https://doi.org/10.1186/s40942-017-0084-9.

4. Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications;Kang-Mieler;Expert Opinion on Drug Delivery,2017

5. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins;Aiello;Proc. Natl. Acad. Sci. U. S. A.,1995

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifunctional nano-in-micro delivery systems for targeted therapy in fundus neovascularization diseases;Journal of Nanobiotechnology;2024-06-20

2. Lipid-based nanocarriers challenging the ocular biological barriers: Current paradigm and future perspectives;Journal of Controlled Release;2023-10

3. An Update on Strategies to Deliver Protein and Peptide Drugs to the Eye;ACS Omega;2023-09-22

4. Bevacizumab-loaded CalliSpheres beads: in vitro loading, release profiles and application in rabbit liver VX2 tumor model;Frontiers in Oncology;2023-07-19

5. Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases;Pharmaceutics;2023-06-15